This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • General Rhinology  • Paranasal Sinus Disease  • Pulmonary Diseases  • Pulmonary Diseases, Other  • Liver/ Biliary Tract/ Pancreatic Diseases  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Eileen M. Raynor, MD; Allen Butler, MD; Margaret Guill, MD; John P. Bent III, MD

Arch Otolaryngol Head Neck Surg. 2000;126:581-583.

Objective  To determine the benefit of nasally inhaled dornase alfa in cystic fibrosis (CF) sinusitis.

Design  Retrospective chart review comparing postsurgical course, radiographic studies, and pulmonary function test results in patients who were treated with nasally inhaled dornase alfa with those in patients who were not treated with dornase alfa.

Patients  Twenty consecutive patients with CF who underwent functional endoscopic sinus surgery from 1993 to 1997 were included in the study. Treatment with nasally inhaled dornase alfa was initiated in 5 of the 20 patients after they underwent functional endoscopic sinus surgery.

Setting  Tertiary care academic center.

Results  The dornase alfa–treated patients had less mucosal edema and no polyps at serial endoscopy over 3 years compared with the non–dornase alfa–treated patients. The patients who received nasally inhaled dornase alfa also underwent fewer revision functional endoscopic sinus surgical procedures (1.6 vs 3.2), even though there was essentially no change in pulmonary function test results in these patients.

Conclusions  Sinusitis continues to be a major cause of morbidity in patients with CF. Symptomatic patients frequently require multiple drug regimens, including long-term systemic antibiotic therapy, topical and systemic steroid therapy, and antibiotic nasal irrigations. This preliminary study indicates the potential impact of nasally inhaled dornase alfa in controlling postoperative symptoms in CF sinusitis.

From the Department of Otolaryngology, University of Florida–Health Science Center Jacksonville (Dr Raynor); the Department of Surgery, Division of Otolaryngology (Dr Butler), and the Division of Pulmonary Medicine (Dr Guill), Medical College of Georgia, Augusta; and New York Ear Associates, Lenox Hill, NY (Dr Bent).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dornase Alfa as Postoperative Therapy in Cystic Fibrosis Sinonasal Disease
Cimmino et al.
Arch Otolaryngol Head Neck Surg 2005;131:1097-1101.
ABSTRACT | FULL TEXT